NephroGenex
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3200 Beechleaf Ct Ste 900, Raleigh, Nort...Phone Number
(609) 986-1780Website
www.nephrogenex.comRevenue
<$5 MillionIndustry
About NephroGenex
NephroGenex, Inc is an innovator in the development of drugs aimed at treating kidney disease, particularly focusing on diabetic nephropathy. Their lead drug candidate, PYRIDORIN® (pyridoxamine dihydrochloride), effectively inhibits pathogenic oxidative chemistries associated with the progression of diabetic nephropathy and end-stage renal disease. The company has secured FDA Fast Track designation and Special Protocol Assessment for its Phase 3 Pyridorin program, highlighting its potential as a breakthrough therapy in a field with limited treatment options. NephroGenex targets patients suffering from chronic kidney disease and acute kidney injury, aiming to improve their health outcomes through innovative therapies.Explore more
NephroGenex Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to NephroGenex
Compare insights from companies similar to NephroGenex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NephroGenex
Sign Up For FreeTo access detailed company insights
NephroGenex, Inc is an innovator in the development of drugs aimed at treating kidney disease, particularly focusing on diabetic nephropathy. Their lead drug candidate, PYRIDORIN® (pyridoxamine dihydrochloride), effectively inhibits pathogenic oxidative chemistries associated with the progression of diabetic nephropathy and end-stage renal disease.... Read More
